AU2012258902A1 - Ocular ultrasound probe - Google Patents
Ocular ultrasound probe Download PDFInfo
- Publication number
- AU2012258902A1 AU2012258902A1 AU2012258902A AU2012258902A AU2012258902A1 AU 2012258902 A1 AU2012258902 A1 AU 2012258902A1 AU 2012258902 A AU2012258902 A AU 2012258902A AU 2012258902 A AU2012258902 A AU 2012258902A AU 2012258902 A1 AU2012258902 A1 AU 2012258902A1
- Authority
- AU
- Australia
- Prior art keywords
- probe
- ocular
- ultrasound
- ultrasound probe
- housing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000002604 ultrasonography Methods 0.000 title claims description 233
- 239000000523 sample Substances 0.000 title claims description 201
- 238000000034 method Methods 0.000 claims description 38
- 238000011282 treatment Methods 0.000 claims description 27
- 230000003287 optical effect Effects 0.000 claims description 23
- 208000004644 retinal vein occlusion Diseases 0.000 claims description 19
- 210000001210 retinal vessel Anatomy 0.000 claims description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 10
- 230000004386 ocular blood flow Effects 0.000 claims description 8
- 201000010099 disease Diseases 0.000 claims description 5
- 208000035475 disorder Diseases 0.000 claims description 5
- 210000000695 crystalline len Anatomy 0.000 description 15
- 239000003814 drug Substances 0.000 description 13
- 230000000694 effects Effects 0.000 description 12
- 239000002872 contrast media Substances 0.000 description 10
- 210000000744 eyelid Anatomy 0.000 description 10
- 230000001225 therapeutic effect Effects 0.000 description 9
- 208000022873 Ocular disease Diseases 0.000 description 8
- 230000002207 retinal effect Effects 0.000 description 8
- 239000000853 adhesive Substances 0.000 description 7
- 230000001070 adhesive effect Effects 0.000 description 7
- 229940079593 drug Drugs 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 230000017531 blood circulation Effects 0.000 description 6
- 210000001519 tissue Anatomy 0.000 description 6
- 210000001525 retina Anatomy 0.000 description 5
- 208000007536 Thrombosis Diseases 0.000 description 4
- 238000003384 imaging method Methods 0.000 description 4
- 229910052451 lead zirconate titanate Inorganic materials 0.000 description 4
- 210000004279 orbit Anatomy 0.000 description 4
- 238000012800 visualization Methods 0.000 description 4
- 230000002411 adverse Effects 0.000 description 3
- 238000002583 angiography Methods 0.000 description 3
- 230000000740 bleeding effect Effects 0.000 description 3
- 201000005667 central retinal vein occlusion Diseases 0.000 description 3
- 238000010253 intravenous injection Methods 0.000 description 3
- 238000011457 non-pharmacological treatment Methods 0.000 description 3
- 238000012014 optical coherence tomography Methods 0.000 description 3
- 210000003462 vein Anatomy 0.000 description 3
- 201000004569 Blindness Diseases 0.000 description 2
- KSFOVUSSGSKXFI-GAQDCDSVSA-N CC1=C/2NC(\C=C3/N=C(/C=C4\N\C(=C/C5=N/C(=C\2)/C(C=C)=C5C)C(C=C)=C4C)C(C)=C3CCC(O)=O)=C1CCC(O)=O Chemical compound CC1=C/2NC(\C=C3/N=C(/C=C4\N\C(=C/C5=N/C(=C\2)/C(C=C)=C5C)C(C=C)=C4C)C(C)=C3CCC(O)=O)=C1CCC(O)=O KSFOVUSSGSKXFI-GAQDCDSVSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000002607 contrast-enhanced ultrasound Methods 0.000 description 2
- 210000004087 cornea Anatomy 0.000 description 2
- 238000002059 diagnostic imaging Methods 0.000 description 2
- 208000037765 diseases and disorders Diseases 0.000 description 2
- 210000004709 eyebrow Anatomy 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 230000004410 intraocular pressure Effects 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000013307 optical fiber Substances 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 238000011458 pharmacological treatment Methods 0.000 description 2
- 229950003776 protoporphyrin Drugs 0.000 description 2
- 210000001957 retinal vein Anatomy 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 229940124597 therapeutic agent Drugs 0.000 description 2
- 210000001585 trabecular meshwork Anatomy 0.000 description 2
- WLCZTRVUXYALDD-IBGZPJMESA-N 7-[[(2s)-2,6-bis(2-methoxyethoxycarbonylamino)hexanoyl]amino]heptoxy-methylphosphinic acid Chemical compound COCCOC(=O)NCCCC[C@H](NC(=O)OCCOC)C(=O)NCCCCCCCOP(C)(O)=O WLCZTRVUXYALDD-IBGZPJMESA-N 0.000 description 1
- 208000010412 Glaucoma Diseases 0.000 description 1
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 208000014139 Retinal vascular disease Diseases 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 230000003872 anastomosis Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229960000397 bevacizumab Drugs 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000012489 doughnuts Nutrition 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000004880 explosion Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 229960004716 idoxuridine Drugs 0.000 description 1
- 238000012905 input function Methods 0.000 description 1
- 238000005305 interferometry Methods 0.000 description 1
- HFGPZNIAWCZYJU-UHFFFAOYSA-N lead zirconate titanate Chemical group [O-2].[O-2].[O-2].[O-2].[O-2].[Ti+4].[Zr+4].[Pb+2] HFGPZNIAWCZYJU-UHFFFAOYSA-N 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229940083224 ozurdex Drugs 0.000 description 1
- 229960003407 pegaptanib Drugs 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000000649 photocoagulation Effects 0.000 description 1
- 230000001443 photoexcitation Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000009417 prefabrication Methods 0.000 description 1
- 229960003876 ranibizumab Drugs 0.000 description 1
- 230000010410 reperfusion Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000001839 systemic circulation Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000009210 therapy by ultrasound Methods 0.000 description 1
- 229960000103 thrombolytic agent Drugs 0.000 description 1
- 230000002537 thrombolytic effect Effects 0.000 description 1
- GFNANZIMVAIWHM-OBYCQNJPSA-N triamcinolone Chemical compound O=C1C=C[C@]2(C)[C@@]3(F)[C@@H](O)C[C@](C)([C@@]([C@H](O)C4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 GFNANZIMVAIWHM-OBYCQNJPSA-N 0.000 description 1
- 229960005294 triamcinolone Drugs 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 210000005166 vasculature Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 229910052724 xenon Inorganic materials 0.000 description 1
- FHNFHKCVQCLJFQ-UHFFFAOYSA-N xenon atom Chemical compound [Xe] FHNFHKCVQCLJFQ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N7/00—Ultrasound therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/10—Eye inspection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/42—Details of probe positioning or probe attachment to the patient
- A61B8/4272—Details of probe positioning or probe attachment to the patient involving the acoustic interface between the transducer and the tissue
- A61B8/429—Details of probe positioning or probe attachment to the patient involving the acoustic interface between the transducer and the tissue characterised by determining or monitoring the contact between the transducer and the tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/44—Constructional features of the ultrasonic, sonic or infrasonic diagnostic device
- A61B8/4438—Means for identifying the diagnostic device, e.g. barcodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/48—Diagnostic techniques
- A61B8/481—Diagnostic techniques involving the use of contrast agents, e.g. microbubbles introduced into the bloodstream
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/90—Identification means for patients or instruments, e.g. tags
- A61B90/98—Identification means for patients or instruments, e.g. tags using electromagnetic means, e.g. transponders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
- A61F9/008—Methods or devices for eye surgery using laser
- A61F9/00821—Methods or devices for eye surgery using laser for coagulation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0092—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin using ultrasonic, sonic or infrasonic vibrations, e.g. phonophoresis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/44—Constructional features of the ultrasonic, sonic or infrasonic diagnostic device
- A61B8/4444—Constructional features of the ultrasonic, sonic or infrasonic diagnostic device related to the probe
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
- A61F9/008—Methods or devices for eye surgery using laser
- A61F2009/00861—Methods or devices for eye surgery using laser adapted for treatment at a particular location
- A61F2009/00863—Retina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/06—Head
- A61M2210/0612—Eyes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N7/00—Ultrasound therapy
- A61N2007/0039—Ultrasound therapy using microbubbles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N7/00—Ultrasound therapy
- A61N2007/0052—Ultrasound therapy using the same transducer for therapy and imaging
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N7/00—Ultrasound therapy
- A61N2007/0056—Beam shaping elements
- A61N2007/0065—Concave transducers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Surgery (AREA)
- Physics & Mathematics (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Radiology & Medical Imaging (AREA)
- Molecular Biology (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- Ophthalmology & Optometry (AREA)
- Hematology (AREA)
- Electromagnetism (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Optics & Photonics (AREA)
- Vascular Medicine (AREA)
- Acoustics & Sound (AREA)
- Dermatology (AREA)
- Anesthesiology (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
- Eye Examination Apparatus (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161488505P | 2011-05-20 | 2011-05-20 | |
| US61/488,505 | 2011-05-20 | ||
| US201161577525P | 2011-12-19 | 2011-12-19 | |
| US61/577,525 | 2011-12-19 | ||
| PCT/US2012/038900 WO2012162272A1 (en) | 2011-05-20 | 2012-05-21 | Ocular ultrasound probe |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2012258902A1 true AU2012258902A1 (en) | 2014-01-16 |
Family
ID=47217667
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2012258902A Abandoned AU2012258902A1 (en) | 2011-05-20 | 2012-05-21 | Ocular ultrasound probe |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US20130046179A1 (enExample) |
| EP (1) | EP2712310A4 (enExample) |
| JP (2) | JP2014523263A (enExample) |
| AU (1) | AU2012258902A1 (enExample) |
| WO (1) | WO2012162272A1 (enExample) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010110823A1 (en) | 2009-03-27 | 2010-09-30 | Bing Innovations, Llc | Apparatus and method for reducing pain during skin puncturing procedures |
| US9168340B2 (en) | 2009-03-27 | 2015-10-27 | Bing Innovations, Llc | System and method for pain reduction during skin puncture and breakable tip therefor |
| US9463287B1 (en) * | 2004-09-20 | 2016-10-11 | Bing Innovations, Llc | Controlling usage of replaceable tool ends |
| WO2011091020A2 (en) | 2010-01-19 | 2011-07-28 | The Board Of Regents Of The University Of Texas System | Apparatuses and systems for generating high-frequency shockwaves, and methods of use |
| AR087170A1 (es) | 2011-07-15 | 2014-02-26 | Univ Texas | Aparato para generar ondas de choque terapeuticas y sus aplicaciones |
| EP2869895A4 (en) * | 2012-07-03 | 2016-07-20 | Doheny Eye Inst | SOUNDING METHOD |
| US10835767B2 (en) * | 2013-03-08 | 2020-11-17 | Board Of Regents, The University Of Texas System | Rapid pulse electrohydraulic (EH) shockwave generator apparatus and methods for medical and cosmetic treatments |
| AU2014232195A1 (en) * | 2013-03-15 | 2015-10-15 | Doheny Eye Institute | Management of tractional membranes |
| US9642525B2 (en) * | 2013-11-22 | 2017-05-09 | Johnson & Johnson Vision Care, Inc. | Ophthalmic lens with retinal vascularization monitoring system |
| CN104000624B (zh) * | 2014-04-24 | 2016-04-13 | 温州医科大学 | 一种贴于眼表用于眼轴测量的超声探头 |
| US20160023020A1 (en) * | 2014-07-24 | 2016-01-28 | Strathspey Crown Holdings, LLC | System and Method for Inducing a Post-Operative Posterior Vitreous Detachment |
| US10695508B2 (en) | 2015-05-01 | 2020-06-30 | Bing Innovations, Llc | Reducing pain of skin piercing using vibration |
| CA2985811A1 (en) | 2015-05-12 | 2016-11-17 | Soliton, Inc. | Methods of treating cellulite and subcutaneous adipose tissue |
| WO2017165595A1 (en) | 2016-03-23 | 2017-09-28 | Soliton, Inc. | Pulsed acoustic wave dermal clearing system and method |
| CN105997152A (zh) * | 2016-06-13 | 2016-10-12 | 杭州融超科技有限公司 | 一体式瞳孔测量装置、使用该装置的数据处理方法和系统 |
| WO2017216800A1 (en) | 2016-06-16 | 2017-12-21 | Hadasit Medical Research Services And Development Ltd. | Device and method for determination of pupil size in a subject having closed eyelids |
| TW202448390A (zh) | 2016-07-21 | 2024-12-16 | 美商席利通公司 | 具備改良電極壽命之快速脈波電動液壓脈衝產生裝置 |
| WO2018039729A1 (en) * | 2016-08-31 | 2018-03-08 | Centre For Eye Research Australia Limited | Ultrasound apparatus and system |
| KR102587035B1 (ko) | 2017-02-19 | 2023-10-10 | 솔리톤, 인코포레이티드 | 생물학적 매체 내의 선택적 레이저 유도 광학 파괴 |
| CA3089618A1 (en) | 2018-01-26 | 2019-08-01 | Bing Innovations, L.L.C. | Reducing pain at a medical treatment site |
| CN108852415A (zh) * | 2018-05-07 | 2018-11-23 | 深圳市德力凯医疗设备股份有限公司 | 一种经颅三维脑血管复合成像方法及系统 |
| BR112021019737A2 (pt) | 2019-04-03 | 2021-12-07 | Soliton Inc | Sistemas, dispositivos, e métodos de tratamento de tecido e celulite por subcisão acústica não invasiva |
| CN111729188B (zh) | 2020-06-24 | 2023-07-14 | 南京超维景生物科技有限公司 | 超声引导的载药微泡递送方法及装置 |
| KR102409743B1 (ko) * | 2021-03-30 | 2022-06-16 | 텐텍 주식회사 | 시력 회복 안경에 이용되는 진동부 |
| WO2024212220A1 (zh) * | 2023-04-14 | 2024-10-17 | 李佩倞 | 微泡在制备联合超声产生小幅谐振或稳态空化作为治疗缺血性眼病药物中的用途 |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3948248A (en) * | 1974-09-05 | 1976-04-06 | Zuckerman Joel L | Method of measuring ocular pulse |
| US4484569A (en) * | 1981-03-13 | 1984-11-27 | Riverside Research Institute | Ultrasonic diagnostic and therapeutic transducer assembly and method for using |
| US4930512A (en) * | 1988-06-16 | 1990-06-05 | Sonomed, Inc. | Hand held spring-loaded ultrasonic probe |
| US5331962A (en) * | 1993-04-16 | 1994-07-26 | Cornell Research Foundation Inc. | Ultrasound system for corneal biometry |
| JPH08322803A (ja) * | 1995-05-31 | 1996-12-10 | Canon Inc | 眼圧計 |
| WO2001049227A1 (en) * | 2000-01-03 | 2001-07-12 | Johns Hopkins University | Surgical devices and methods of use thereof for enhanced tactile perception |
| US6497665B1 (en) * | 2000-07-14 | 2002-12-24 | Koninklijke Philips Electronics N.V. | System and method for non-linear detection of ultrasonic contrast agents at a fundamental frequency |
| US6638228B1 (en) * | 2002-04-26 | 2003-10-28 | Koninklijke Philips Electronics N.V. | Contrast-agent enhanced color-flow imaging |
| EP1591073A4 (en) * | 2003-01-31 | 2010-11-17 | Hitachi Medical Corp | ULTRASONIC SOUND AND ULTRASONIC UNIT |
| BRPI0507690A (pt) * | 2004-02-12 | 2007-07-24 | Neovista Inc | métodos e aparelho para a braquiterapia intra-ocular |
| US7618372B2 (en) * | 2004-07-02 | 2009-11-17 | Dela Houssaye Arthur Joseph | Laser guided eye measuring device and method for using |
| JP4992071B2 (ja) * | 2005-07-29 | 2012-08-08 | 国立大学法人 鹿児島大学 | 眼球組織への生理活性薬剤導入のための組成物及び装置 |
| WO2007081750A2 (en) * | 2006-01-06 | 2007-07-19 | The Curators Of The University Of Missouri | Ultrasound-mediated transcleral drug delivery |
| JP4953282B2 (ja) * | 2006-05-18 | 2012-06-13 | 株式会社ニデック | 眼科用手術支援装置 |
| US20080262512A1 (en) * | 2007-04-02 | 2008-10-23 | Doheny Eye Institute | Thrombolysis In Retinal Vessels With Ultrasound |
| US8764658B2 (en) * | 2007-04-02 | 2014-07-01 | Doheny Eye Institute | Ultrasound and microbubbles in ocular diagnostics and therapies |
| JP5080961B2 (ja) * | 2007-12-27 | 2012-11-21 | 俊郎 立花 | 眼科用超音波治療装置 |
| JP5698538B2 (ja) * | 2007-12-28 | 2015-04-08 | コーニンクレッカ フィリップス エヌ ヴェ | 組織切除装置、組織切除システム、及び組織切除術の実行を監視するためのプログラム |
| EP2092916A1 (en) * | 2008-02-19 | 2009-08-26 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | A method of treating an ocular pathology by applying high intensity focused ultrasound and device thereof |
| JP2009254779A (ja) * | 2008-03-26 | 2009-11-05 | Nidek Co Ltd | 眼科用超音波診断装置 |
| US9314421B2 (en) * | 2009-03-06 | 2016-04-19 | The Hong Kong University Of Science And Technology | Ultrasound-enhanced intrascleral delivery of macromolecules |
| WO2010107930A1 (en) * | 2009-03-17 | 2010-09-23 | The Uwm Research Foundation, Inc. | Ultrasonic imaging device |
| US20120116221A1 (en) * | 2009-04-09 | 2012-05-10 | The Trustees Of The University Of Pennsylvania | Methods and systems for image-guided treatment of blood vessels |
| WO2013149260A1 (en) * | 2012-03-30 | 2013-10-03 | Humayun Mark S | Method for treatment of ocular disorders |
| EP2833971A4 (en) * | 2012-04-05 | 2016-01-13 | Matthew Bujak | METHOD, SYSTEM AND USE OF THERAPEUTIC ULTRASOUND |
-
2012
- 2012-05-21 WO PCT/US2012/038900 patent/WO2012162272A1/en not_active Ceased
- 2012-05-21 US US13/476,984 patent/US20130046179A1/en not_active Abandoned
- 2012-05-21 AU AU2012258902A patent/AU2012258902A1/en not_active Abandoned
- 2012-05-21 JP JP2014511616A patent/JP2014523263A/ja active Pending
- 2012-05-21 EP EP12790216.1A patent/EP2712310A4/en not_active Withdrawn
-
2014
- 2014-05-07 US US14/272,161 patent/US20140343432A1/en not_active Abandoned
-
2018
- 2018-02-02 JP JP2018016988A patent/JP2018110868A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP2712310A4 (en) | 2014-12-10 |
| EP2712310A1 (en) | 2014-04-02 |
| US20140343432A1 (en) | 2014-11-20 |
| WO2012162272A1 (en) | 2012-11-29 |
| US20130046179A1 (en) | 2013-02-21 |
| JP2014523263A (ja) | 2014-09-11 |
| JP2018110868A (ja) | 2018-07-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20140343432A1 (en) | Ocular ultrasound probe | |
| US10966738B2 (en) | Ocular ultrasound probe | |
| US8764658B2 (en) | Ultrasound and microbubbles in ocular diagnostics and therapies | |
| JP7463584B2 (ja) | 薬物の超音波強化送達のためのシステムおよび方法 | |
| JP5490826B2 (ja) | 単一の曲率を有した凹面状部分の形状を呈する超音波ビーム発生手段を備えた超音波装置 | |
| CN108472017A (zh) | 用于眼部治疗的超声引导空化方法和系统 | |
| JP2002528212A (ja) | 接触装置を使用した信号の発信と検査の方向及び装置 | |
| JP2014523263A5 (enExample) | ||
| US20180001114A1 (en) | Automated ultrasound apparatus and method for noninvasive vessel recanalization treatment and monitoring | |
| US10188843B2 (en) | Ultrasound and microbubbles in ocular diagnostics and therapies | |
| Wang et al. | Real-time cavitation monitoring during optical coherence tomography guided photo-mediated ultrasound therapy of the retina | |
| US20150173949A1 (en) | Sonolysis method | |
| US20230142825A1 (en) | Therapeutic method for the eye using ultrasound | |
| CN110113984A (zh) | 氧饱和度的超声引导光声监测 | |
| US11511138B2 (en) | Method and apparatus for removing microvessels | |
| US20250195033A1 (en) | Method And Device For Determining Intracranial Pressure Of A Patient | |
| US9610062B2 (en) | Perioperative ocular distention (POD) monitor | |
| CN114209275A (zh) | 一种兼容oct的光声传感器 | |
| US10736571B1 (en) | Glaucoma testing device and a method using the same | |
| Wang | The Applications of Photo-mediated Ultrasound Therapy in Vascular Diseases | |
| Siebler | Neuro-orbital ultrasound | |
| Hemmerling et al. | Ocular ultrasonography | |
| Tran et al. | Ocular 22 | |
| CHENNAI | EVALUATION OF POSTERIOR SEGMENT PATHOLOGY USING B SCAN IN PATIENTS WITH OPAQUE MEDIA POSTED FOR CATARACT SURGERY |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK5 | Application lapsed section 142(2)(e) - patent request and compl. specification not accepted |